Navigation Links
New UK study shows potential for targeting aggressive breast cancers
Date:2/11/2014

LEXINGTON, Ky. (Feb. 10, 2014) A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition (EMT) program in human cells, may provide an effective approach for treating triple-negative breast cancer.

Triple-negative breast cancer has an activated EMT program, which is a process that provides cells with the increased plasticity (or flexibility) to adapt to stressed environments during embryonic development, wound healing, tissue fibrosis and metastasis. EMT provides tumor cells with stem cell-like characteristics, making them resistant to therapeutics and increasing their chances for early metastasis.

Triple-negative breast cancer in particular is associated with an aggressive clinical history, development of recurrence, distant metastasis and shorter patient survival, especially in younger women. It lacks effective targeted therapies and often displays early metastatic spread to brain and lung, sites known to be associated with an estimated 5-year survival of less than 20 percent.

Published in Cancer Cell, the study found that the nuclear protein Twist acts similarly to a virus protein. Using protein purification, Zhou's team identified that Twist interacted with a key nuclear transcription regulator BRD4. When many DNA viruses (such as papillomaviruses) enter into human "host" cells during infection, they hijack host cell machinery to replicate and synthesis their viral DNA and proteins. BRD4 is the virus's favored molecule and is often seized by DNA papillomaviruses for gene transcription during replication and growth.

Twist uses a similar strategy to recruit BRD4 to the genomic regions that are regulated by Twist. Many of these genomic regions contain oncogenes, such as those of survival proteins, growth factors and molecules that enhance cell migration and invasion. By recruiting BRD
'/>"/>

Contact: Allison Perry
allison.perry@uky.edu
859-323-2399
University of Kentucky
Source:Eurekalert

Page: 1 2

Related medicine news :

1. UNC study reveals potential route to bladder cancer diagnostics, treatments
2. Dartmouth study provides first global evidence that foreign aid boosts public opinion
3. Study: Resilience in parents of children undergoing stem cell transplant
4. Grant supports Cedars-Sinai study of possible links between air pollution and brain cancer
5. Study provides surprising new clue to the roots of hunger
6. Study identifies protein to repair damaged brain tissue in MS
7. Ice ages arctic tundra lush with wildflowers for woolly mammoths, study finds
8. Director of Womens Guild Lung Institute awarded grant to study treatment for lung disease
9. Columbia study finds hospitals dont follow infection prevention rules
10. Penn study reveals genetics impact risk of early menopause among some female smokers
11. New study finds feeling in control can help you live longer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , ... July 07, 2015 , ... Difass USA, a ... help pass those long, stressful days at work is knowing that there is hopefully ... laid back and stress free as imagined. Planning for a vacation can be quite ...
(Date:7/7/2015)... Angeles, CA (PRWEB) , ... July 07, 2015 ... ... International Business Times highlights rumors about possible facial rejuvenation that have emerged about ... year-old former U.S. Secretary of State looks more youthful than she has in ...
(Date:7/7/2015)... ... July 07, 2015 , ... Greatist today announced the ... helps active people find the most fun activities to do with friends. , The ... It also increases Greatist’s opportunity for events, e-commerce, and brand partnerships. , “I’ve been ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... only industry group whose board is limited to permit holders. The Medical Cannabis ... how to move the industry forward and are committed to making sure patients ...
(Date:7/7/2015)... ... July 07, 2015 , ... At the end of June Pacific Prime Renewals team in Hong ... This initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not only reduce but ... this initiative Cotton explained, “We send anything between 300 and 600 pieces of paper per ...
Breaking Medicine News(10 mins):Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2
... prepare for a day without cigarettes and tobacco products ... Smokeout (R) (November 21), new research gives them more ... to the American Academy of Otolaryngology-Head and Neck Surgery ... organization,s annual meeting in September 2008 are studies that ...
... Nelson, PhD, served as vice-chair of the advisory committee ... by the U.S. Department of Health and Human Services ... for Physical Activity and Nutrition and Associate Professor of ... Policy at Tufts. , "After reviewing a ...
... A further new multidisciplinary journal in the neurosciences, ... March 2009. With this addition to its publishing ... of research, current practices and future trends in the ... the gap between the life sciences, social sciences, engineering, ...
... Institute have found that reducing the levels of vascular endothelial ... of new blood vessel growth, in adult mice causes the ... retina that are essential to visual function. This finding, published ... implications for the chronic use of promising new anti-VEGF drugs ...
... WOBURN, Mass., Nov. 3 Culbert Healthcare,Solutions, ... services firm, announced today that Norm Botsford ... the Strategic Services practice., Mr. Botsford ... Officer,at University Physicians Healthcare (UPH), the health ...
... Scientists at Schepens Eye Research,Institute have found that reducing ... best known as a stimulator of new blood,vessel growth, ... Muller,glia -- cells of the retina that are essential ... 2008 PLoS ONE, holds implications for,the chronic use of ...
Cached Medicine News:Health News:Smokers see decline in ability to smell, rise in laryngitis, and upper airway issues 2Health News:Tufts' Nelson a leader on Physical Activity Guidelines advisory committee 2Health News:Springer launches Cognitive Computation 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 3Health News:Norm Botsford Joins Culbert Healthcare Solutions' Strategic Services Team 2Health News:Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution 2Health News:Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution 3
(Date:7/7/2015)... -- Research and Markets ( ... "The New Trends of Global Preclinical Development ... The report, The New Trends of Global ... the current development states and the future growth ... The report is designed to reveal the latest ...
(Date:7/7/2015)... MILAN , July 7, 2015 /PRNewswire/ ... que la société P&R annonce l,acquisition de ... active au niveau mondial, spécialisée dans la ... à base d,acide hyaluronique.      ... est l,un des principaux groupes chimiques et ...
(Date:7/7/2015)... WASHINGTON , July 7, 2015 Noting ... and opaque" pricing policies currently practiced by the rapidly ... Pharmacy Coalition (SCPC) today praised Ohio ... into law a new state effort to help pull ... practices. "We applaud Governor Kasich for ...
Breaking Medicine Technology:New Trends in the 2015 Global Preclinical Development Outsourcing Market 2New Trends in the 2015 Global Preclinical Development Outsourcing Market 3New Trends in the 2015 Global Preclinical Development Outsourcing Market 4New Trends in the 2015 Global Preclinical Development Outsourcing Market 5National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 2National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 3
... 2011 A new report in the March issue of ... beat brand names when it comes to safety, efficacy, and ... drug programs offering these drugs at prices as low as ... Walgreens, and Walmart have been steadily expanding their discount programs, ...
... JumpStart Ventures , the non-profit that invests in ... Ohio, and Cleveland Clinic , announced a ... Inc. The Cleveland-based company is developing a topical ... formation in wounds. (Logo: http://photos.prnewswire.com/prnh/20060209/CLJUMPSTARTLOGO) ...
Cached Medicine Technology:Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 2Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 3Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 4JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 2JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 3JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 4
Albumin FS for determination of albumin in serum or plasma. For Hitachi 704 / 911. Available with Calibrator: Trucal U and Controls: Trulab N and Trulab P....
For the quantitative determination of Albumin in serum. Endpoint procedure with Amax at 630 nm. Linearity: to 6 g/dl. Liquid ready-to-use reagent....
ASAT (GOT) FS (IFCC mod). For determination of ASAT (GOT) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
AST (SGOT) reagent is used for the quantitative determination of aspartate aminotransferase (AST) in human serum....
Medicine Products: